Completed

A Study of LY3493269 in Participants With Type 2 Diabetes

J1X-MC-GZHC - ClinicalTrials.gov - NCT04515576

The main purpose of this study is to determine the side effects related to LY3493269 in participants with type 2 diabetes.
How long will I be in the trial?
The study will last up to approximately 16 weeks for each participant and may include up to 11 visits.
Email
Completed

A Study of LY3493269 in Participants With Type 2 Diabetes

J1X-MC-GZHC - ClinicalTrials.gov - NCT04515576

The main purpose of this study is to determine the side effects related to LY3493269 in participants with type 2 diabetes.
How long will I be in the trial?
The study will last up to approximately 16 weeks for each participant and may include up to 11 visits.
Email

Key Requirements

Age :

18-70

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have type 2 diabetes that is under control, and HbA1c of at least 7.0% and no more than 10.5%

Participants must have stable body weight for the last three months

Participants must follow birth control requirements

Participants must NOT

Participants must not have type 1 diabetes

Participants must not have uncontrolled diabetes (meaning that they required hospitalization for treatment of life-threatening complications of diabetes) in the last six months

Participants must not have had more than one episode of severe low blood sugar requiring emergency treatment within the last six months

Participants must not take blood sugar lowering drugs, other than a stable dose of metformin, within the last three months

Participants must not have other serious or unstable illnesses

Participants must not have undergone weight loss surgery (stomach stapling, lapbanding, etc.) or have taken prescription weight loss medicine within the last three months

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY3493269

Could I receive a Placebo?

yes

Enrollment Goal

56

Trial Dates

August 2020 - March 2021

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have type 2 diabetes that is under control, and HbA1c of at least 7.0% and no more than 10.5%

Participants must have stable body weight for the last three months

Participants must follow birth control requirements

Participants must NOT

Participants must not have type 1 diabetes

Participants must not have uncontrolled diabetes (meaning that they required hospitalization for treatment of life-threatening complications of diabetes) in the last six months

Participants must not have had more than one episode of severe low blood sugar requiring emergency treatment within the last six months

Participants must not take blood sugar lowering drugs, other than a stable dose of metformin, within the last three months

Participants must not have other serious or unstable illnesses

Participants must not have undergone weight loss surgery (stomach stapling, lapbanding, etc.) or have taken prescription weight loss medicine within the last three months

Participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY3493269

Could I receive a Placebo?

yes

Enrollment Goal

56

Trial Dates

August 2020 - March 2021

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Adult Type 2 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?